Free Trial

Glanbia (OTCMKTS:GLAPY) Hits New 12-Month High - Still a Buy?

Glanbia logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • 52-week high: Glanbia's ADR reached a new 52-week high of $102.21 (prior close $99.00) during mid-day trading, though volume was light at just 153 shares.
  • Consensus "Hold": Analysts now show a consensus "Hold" rating after recent moves, including Kepler Capital Markets downgrading from "strong-buy" to "hold" and Zacks assigning a "hold."
  • Technical and financials show momentum and moderate balance-sheet strength, with a 50‑day MA of $98.47 vs a 200‑day MA of $89.30, debt/equity of 0.38, quick ratio 0.81 and current ratio 1.36.
  • Interested in Glanbia? Here are five stocks we like better.

Glanbia Plc ADR (OTCMKTS:GLAPY - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $102.21 and last traded at $102.21, with a volume of 153 shares changing hands. The stock had previously closed at $99.00.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on GLAPY shares. Kepler Capital Markets cut Glanbia from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 4th. Zacks Research upgraded Glanbia to a "hold" rating in a report on Tuesday, March 3rd. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Glanbia currently has a consensus rating of "Hold".

Check Out Our Latest Research Report on Glanbia

Glanbia Price Performance

The company has a 50-day moving average of $98.47 and a 200 day moving average of $89.30. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.81 and a current ratio of 1.36.

Glanbia Company Profile

(Get Free Report)

Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland. The company operates through two principal divisions: Performance Nutrition and Glanbia Nutritionals. Performance Nutrition develops and markets sports and lifestyle nutrition products, including powders, bars and ready-to-drink beverages for athletes and fitness enthusiasts. Glanbia Nutritionals supplies dairy-based ingredients, specialty cheeses, whey proteins, nutrient premixes and functional food solutions to food, beverage and supplement manufacturers worldwide.

Glanbia was formed in 1997 through the merger of Avonmore Food plc and Waterford Foods plc.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Glanbia Right Now?

Before you consider Glanbia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.

While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines